Vincent R. Anicetti, Chief Operating Officer at Coherus BioSciences, Inc. (CHRS), sold 2,500 shares at $17.22 ($43K) on 2020-06-17, disclosed to the SEC on 2020-06-19.
Scheduled sale ($43k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CHRS | SELL | 2021-01-21 | $45K | — | Filing → |
| CHRS | SELL | 2020-12-21 | $44K | — | Filing → |
| CHRS | SELL | 2020-12-09 | $324K | — | Filing → |